Literature DB >> 23949435

[Multiparametric imaging with simultaneous MR/PET. Methodological aspects and possible clinical applications].

S Gatidis1, H Schmidt, C D Claussen, N F Schwenzer.   

Abstract

Combined magnetic resonance imaging-positron emission tomography (MR/PET) enables acquisition of a variety of imaging parameters during a single examination including anatomical as well as functional information, such as perfusion, diffusion and metabolism. Numerous studies have shown that the combination of these parameters can improve the diagnostic accuracy for many applications especially in oncological imaging. Due to the amount and the complexity of the acquired multiparametric data there is a need for advanced analytical tools, such as methods of parameter selection and data classification. The present article summarizes these methods and their applications in multiparametric imaging via MR/PET.

Mesh:

Year:  2013        PMID: 23949435     DOI: 10.1007/s00117-013-2496-3

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  37 in total

1.  CBF changes during brain activation: fMRI vs. PET.

Authors:  Ching-Mei Feng; Shalini Narayana; Jack L Lancaster; Paul A Jerabek; Thomas L Arnow; Fang Zhu; Li Hai Tan; Peter T Fox; Jia-Hong Gao
Journal:  Neuroimage       Date:  2004-05       Impact factor: 6.556

Review 2.  Biophysical and physiological origins of blood oxygenation level-dependent fMRI signals.

Authors:  Seong-Gi Kim; Seiji Ogawa
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-07       Impact factor: 6.200

3.  Computer-aided diagnosis of prostate cancer in the peripheral zone using multiparametric MRI.

Authors:  Emilie Niaf; Olivier Rouvière; Florence Mège-Lechevallier; Flavie Bratan; Carole Lartizien
Journal:  Phys Med Biol       Date:  2012-05-29       Impact factor: 3.609

Review 4.  Tissue-specific MR contrast agents.

Authors:  Hanns-Joachim Weinmann; Wolfgang Ebert; Bernd Misselwitz; Heribert Schmitt-Willich
Journal:  Eur J Radiol       Date:  2003-04       Impact factor: 3.528

Review 5.  Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging.

Authors:  R Kumar; H Dhanpathi; S Basu; D Rubello; S Fanti; A Alavi
Journal:  Q J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 2.346

Review 6.  Practical medical applications of quantitative MR relaxometry.

Authors:  Hai-Ling Margaret Cheng; Nikola Stikov; Nilesh R Ghugre; Graham A Wright
Journal:  J Magn Reson Imaging       Date:  2012-10       Impact factor: 4.813

7.  Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner.

Authors:  Gaspar Delso; Sebastian Fürst; Björn Jakoby; Ralf Ladebeck; Carl Ganter; Stephan G Nekolla; Markus Schwaiger; Sibylle I Ziegler
Journal:  J Nucl Med       Date:  2011-11-11       Impact factor: 10.057

8.  Quantitative volumetric analysis of gliomas with sequential MRI and ¹¹C-methionine PET assessment: patterns of integration in therapy planning.

Authors:  Javier Arbizu; S Tejada; J M Marti-Climent; R Diez-Valle; E Prieto; G Quincoces; C Vigil; M A Idoate; J L Zubieta; I Peñuelas; J A Richter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-19       Impact factor: 9.236

9.  Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method.

Authors:  Stefan Klöppel; Cynthia M Stonnington; Josephine Barnes; Frederick Chen; Carlton Chu; Catriona D Good; Irina Mader; L Anne Mitchell; Ameet C Patel; Catherine C Roberts; Nick C Fox; Clifford R Jack; John Ashburner; Richard S J Frackowiak
Journal:  Brain       Date:  2008-10-03       Impact factor: 13.501

10.  Cerebral blood flow measurement using fMRI and PET: a cross-validation study.

Authors:  Jean J Chen; Marguerite Wieckowska; Ernst Meyer; G Bruce Pike
Journal:  Int J Biomed Imaging       Date:  2008
View more
  2 in total

1.  Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to 18F-FDG PET/CT?

Authors:  Benedikt M Schaarschmidt; Johannes Grueneisen; Martin Metzenmacher; Benedikt Gomez; Thomas Gauler; Christian Roesel; Philipp Heusch; Verena Ruhlmann; Lale Umutlu; Gerald Antoch; Christian Buchbender
Journal:  Eur Radiol       Date:  2016-05-14       Impact factor: 5.315

2.  Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.

Authors:  Ralf S Eschbach; Wolfgang P Fendler; Philipp M Kazmierczak; Marcus Hacker; Axel Rominger; Janette Carlsen; Heidrun Hirner-Eppeneder; Jessica Schuster; Matthias Moser; Lukas Havla; Moritz J Schneider; Michael Ingrisch; Lukas Spaeth; Maximilian F Reiser; Konstantin Nikolaou; Clemens C Cyran
Journal:  PLoS One       Date:  2015-02-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.